If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Dr. Csernansky serves as the Lizzie Gilman Professor and Chair in the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. His research interests include in vivo neuroimaging of neuropsychiatric disorders, especially schizophrenia and Alzheimer disease, clinical trials of cognition-enhancing drugs, and the development of valid animal models for neuropsychiatric disorders. Dr. Csernansky has over 250 peer-reviewed publications, and has also authored several chapters and books, and his research program has received grant support from the National Institute of Mental Health, the National Institute of Aging, and the Department of Veterans Affairs, as well as several foundations and pharmaceutical companies. He is a Distinguished Fellow of the American Psychiatric Association and a member and officer of the American College of Neuropsychopharmacology and the Society of Biological Psychiatry. He has served as an Associate Editor of Schizophrenia Bulletin and on the Editorial Board of Schizophrenia Research and Neuropsychopharmacology.

Certifications and Licenses

Psychiatry

Training Experience

1980Internship, Stanford University Medical Center
1983Residency, Stanford University School of Medicine

Education/Academic qualification

MD, New York University

… → 1979

Research interests

  • Clinical Trial Methodology
  • Cognitive Neuroscience
  • Dementia
  • Interdisciplinary Research
  • Neuroscience
  • Psychiatry
  • Quantitative MRI
  • Schizophrenia

Fingerprint Dive into the research topics where John G Csernansky is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    Brain morphometric differences in youth with and without perinatally-acquired HIV: A cross-sectional study

    for the Pediatric HIV/AIDS Cohort Study (PHACS) and the Pediatric Imaging, Neurocognition, and Genetics (PING) Study, 2020, In : NeuroImage: Clinical. 26, 102246.

    Research output: Contribution to journalArticle

    Open Access
  • The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures

    Kraus, M. S., Gold, J. M., Barch, D. M., Walker, T. M., Chun, C. A., Buchanan, R. W., Csernansky, J. G., Goff, D. C., Green, M. F., Jarskog, L. F., Javitt, D. C., Kimhy, D., Lieberman, J. A., McEvoy, J. P., Mesholam-Gately, R. I., Seidman, L. J., Ball, M. P., Kern, R. S., McMahon, R. P., Robinson, J. & 2 others, Marder, S. R. & Keefe, R. S. E., Mar 2020, In : Schizophrenia Research: Cognition. 19, 100161.

    Research output: Contribution to journalArticle

    Open Access
  • Editorial: Stress and its impact on Alzheimer's Disease

    Dong, H. & Csernansky, J. G., Feb 1 2019, In : Neurobiology of Stress. 10, 100167.

    Research output: Contribution to journalEditorial

    Open Access

    Improving the evaluation of adult mental disorders in the criminal justice system with computerized adaptive testing

    Gibbons, R. D., Smith, J. D., Brown, C. H., Sajdak, M., Tapia, N. J., Kulik, A., Epperson, M. W. & Csernansky, J., Jan 1 2019, In : Psychiatric Services. 70, 11, p. 1040-1043 4 p.

    Research output: Contribution to journalArticle

    Open Access
  • Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results from the Phase 3 Program

    Andorn, A., Graham, J., Csernansky, J., Newcomer, J. W., Shinde, S., Muma, G., Heidbreder, C. & Fava, M., Sep 1 2019, In : Journal of clinical psychopharmacology. 39, 5, p. 428-433 6 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations